Applying human-centered design to the construction of a cirrhosis management clinical decision support system.

"CONFLICTS OF INTEREST Jin Ge receives research support from Merck and Co; and consults for Astellas Pharmaceuticals. Valy Fontil created a clinical decision support technology platform with potential plans to commercialize it. Jennifer C. Lai receives research support from Flagship Pioneering, Pliant, and Vir; consults for Genfit; and serves on an advisory board for Novo Nordisk. The remaining authors have no conflicts to report."

"FUNDING INFORMATION The authors of this study were supported in part by the KL2TR001870 (National Center for Advancing Translational Sciences, Jin Ge), the AASLD Anna S. Lok Advanced/Transplant Hepatology Award AHL21-104606 (AASLD Foundation, Jin Ge), P30DK026743 (UCSF Liver Center Grant, Jin Ge and Jennifer C. Lai), K23HL136899 (National Heart, Lung, and Blood Institute, Valy Fontil), UL1TR001872 (National Center for Advancing Translational Sciences, Mark J. Pletcher), and R01AG059183/K24AG080021 (National Institute on Aging, Jennifer C. Lai). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any other funding agencies. The funding agencies played no role in the analysis of the data or the preparation of this manuscript."